April 5, 2024
Just in time for ketamine: APC updates Constructive Transfer statement
APC’s Board this week approved minor revisions to its policy statement on Constructive Transfer of compounded controlled substance drugs. The statement was first adopted in 2010. The new revisions provide pharmacy compounders with an updated briefing, highlighting the DEA’s recent limited enforcement actions regarding the constructive transfer of controlled substances to physicians. The statement also reiterates the position the DEA has taken regarding pharmacists and their obligations outlined in the federal Controlled Substances Act.
“The provided information aims to support pharmacists in making informed decisions regarding the delivery of controlled substances to prescribers for in-office administration, including certain dosage forms of ketamine,” said APC’s Tenille Davis.
